On January 19, 2022, Runke Bioengineering (Fujian) Co., Ltd. received a notification from ECOCERT SA, the French International Ecological Certification Center, regarding the successful passing of its "Docosahexaenoic Acid Oil," "Aquatic Plant Seaweed," and "DHA Algal Oil" products through the US Organic Certification. This signifies that Runke Bioengineering's DHA algal oil products have obtained a pass to enter the organic food sector in international markets.
Runke Bioengineering (Fujian) Co., Ltd. is a national high-tech enterprise that utilizes modern biotechnology engineering to research, develop, and produce human health products derived from marine microalgae. The company boasts a research and development team led by internationally renowned microalgae technology experts, four provincial and municipal-level engineering technology research and development centers, a corporate microalgae technology research and development platform, well-equipped workshops, and a GMP production base with a 100,000-level standard. The company has obtained certifications such as ISO9001, ISO14001, ISO22000, HACCP, FSSC22000, Non-GMO Identity Preservation (IP), Kosher, US GRAS, and EU SE, adhering to strict quality standards to provide global customers with high-quality products. The company aims to utilize biotechnology engineering to develop marine microalgae and microbial industries, becoming a leading supplier of health food nutritional enhancers, nutritional ingredient raw materials, and nutritional products in China, serving human health with high-quality health products, and transforming Runke Bioengineering into an internationally renowned modern biotechnology enterprise.
On December 20, the State Administration for Market Regulation (hereinafter referred to as "SAMR") issued a consultation document regarding the raw material directory for health food, proposing to include six ingredients such as protein powder and DHA in the directory. SAMR determined the health benefits of DHA based on existing domestic and international scientific consensus, stating that DHA is an essential component of brain cell membranes and plays a crucial role in the formation and development of brain cells. In determining the health benefits of this ingredient, SAMR entrusted the Chinese Nutrition Society to conduct research on the functional representation of the ingredient. After a special discussion organized by the SAMR Evaluation Center, it was ultimately determined that the health benefit of DHA is to "supplement n-3 polyunsaturated fatty acids." This is because n-3 polyunsaturated fatty acids, including DHA, are scientifically recognized as playing an important role not only in brain development but also in regulating blood lipids, blood pressure, and other aspects. Therefore, DHA, as a nutrient required by the human body, is more precise and scientific to be labeled as a "supplement."
As national recommendations and public health awareness deepen, people's understanding of DHA nutrition has also increased. Supplementing DHA during pregnancy, after birth, and during childhood and adolescence, as well as from middle age to old age, DHA is undoubtedly a polyunsaturated fatty acid that benefits lifelong health. This has become a consensus among the nation's health consumers. The consumer base for Runke DHA is extensive and diverse.
With the passing of Runke Bioengineering's "Docosahexaenoic Acid Oil," "Aquatic Plant Seaweed," and "DHA Algal Oil" products through the US Organic Certification, this also signifies that DHA products can not only satisfy their stable and safe applications in traditional areas such as infant formula milk powder and general health food, but will also further expand their addition to the global organic food sector.
